Fredun Pharmaceuticals
950.00
-15.10(-1.56%)
Market Cap₹448.57 Cr
PE Ratio23.08
IndustryHealthcare
Company Performance:
1D-1.56%
1M+13.45%
6M+44.28%
1Y+8.12%
5Y+464.30%
View Company Insightsright
Latest news about Fredun Pharmaceuticals
Fredun Pharma Receives SEBI Adjudication Order: No Financial Penalty Imposed 5 days ago
Fredun Pharmaceuticals Limited has received an adjudication order from SEBI addressing several alleged regulatory violations. The order, dated June 30, 2025, cites issues including non-compliance with Indian Accounting Standards, improper audit report submissions, and corporate governance lapses. Despite the violations, SEBI has not imposed any financial penalty on the company. Fredun Pharma states that the order has no impact on its financial or operational activities.
Fredun Pharmaceuticals Expands into Pet Care with One Pet Stop Acquisition Jun 30, 2025
Fredun Pharma Secures Major Tender from Tamil Nadu Medical Services Corporation Apr 11, 2025
Fredun Pharma Secures Rs. 150-180 Crore Tender from Tamil Nadu Medical Services Corporation Apr 09, 2025
Fredun Pharma's Freossi Division Makes International Debut in Sri Lanka Mar 18, 2025
More news about Fredun Pharmaceuticals
12Mar 25
Fredun Pharmaceuticals Expands Veterinary Portfolio with Large Animal Healthcare Products
Fredun Pharmaceuticals Limited has announced its entry into the large animal healthcare segment with the launch of two new products under the FREOSSI Large Animals brand. The company introduced Freossi Tone+, a lactation solution for large animals, and Freossi Power, focused on strength and mobility for livestock. Both products are formulated with Microcrystalline Hydroxyapatite Complex (MCHC) and other scientifically backed ingredients. This strategic expansion builds on the company's success in companion animal care and aims to strengthen its position in the animal health industry. The move is part of a broader strategy to expand Fredun Pharma's footprint in veterinary healthcare.
11Mar 25
Fredun Pharmaceuticals Expands Veterinary Portfolio with Large Animal Products
Fredun Pharmaceuticals Limited has announced its entry into the large animal products segment, expanding its veterinary healthcare business. The company is launching two new products under the FREOSSI Large Animals brand: Freossi Tone+, a lactation solution, and Freossi Power, a supplement for strength and mobility in livestock. Freossi Tone+ aims to improve milk yield, quality, and lactation cycles in large animals, while Freossi Power targets joint issues and mobility in horses, bulls, ponies, and cattle. This strategic move diversifies Fredun Pharma's product portfolio and strengthens its presence in the animal health sector.
Fredun Pharmaceuticals
950.00
-15.10
(-1.56%)
1 Year Returns:+8.12%
Industry Peers
Sun Pharmaceutical
1,701.00
(-1.53%)
Divis Laboratories
6,831.00
(+0.60%)
Cipla
1,475.80
(-1.01%)
Torrent Pharmaceuticals
3,459.50
(+0.58%)
Mankind Pharma
2,625.50
(-0.96%)
Dr Reddys Laboratories
1,259.40
(-0.12%)
Zydus Life Science
968.90
(+0.13%)
Lupin
1,930.10
(-1.06%)
Abbott
34,280.00
(+0.01%)
Aurobindo Pharma
1,152.90
(+0.08%)